PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary OpGen Announces Launch of Genome-Builder, a Breakthrough Advance for Sequence Assembly and Structure Variation Analysis in Large Genomes
Supporting Data Presented at ASHG Annual Meeting Highlights New Argus Whole Genome Mapping Software Module and Faster, More Accurate Project Completion Capabilities Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 dan@purecommunicationsinc.com OpGen Contact: Judy Macemon VP
View HTML
Toggle Summary OpGen’s Whole Genome Mapping Technology Provides Critical Genomic Information for Malaria Research
New Genetic Variation Discovered in Multi-drug Resistant Plasmodium falciparum Malaria Strain Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 dan@purecommunicationsinc.com OpGen Contact: Judy Macemon VP Marketing, OpGen, Inc. (240) 813-1279 GAITHERSBURG, MD, October 11, 2011 –
View HTML
Toggle Summary Frost & Sullivan New Product Innovation Award Recognizes OpGen’s Argus® Whole Genome Mapping System
Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 dan@purecommunicationsinc.com OpGen Contact: Judy Macemon VP Marketing, OpGen, Inc. (240) 813-1279 GAITHERSBURG, Md.–(BUSINESS WIRE)–OpGen, Inc., a provider of innovative whole genome DNA analysis solutions, announced today the
View HTML
Toggle Summary Optical Mapping First to Definitively Determine Deadly E. coli Strains in German Outbreak Are From a Single Source and Related to Earlier Outbreaks - See more at: http://opgen.com/news/press-releases#sthash.IZ7mrxlV.dpuf
Whole Genome Analysis Adds Crucial Information to Better Understand and Manage the Ongoing E. Coli Outbreak in Germany Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 dan@purecommunicationsinc.com OpGen Contact: Judy Macemon VP Marketing, OpGen, Inc.
View HTML
Toggle Summary The University of Maryland Institute for Genome Sciences (IGS) and OpGen, Inc Announce Collaboration to Develop Microbial Sequence Database
Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 OpGen Contact: Judy Macemon VP Marketing, OpGen, Inc. (858) 472-1474 ASM Booth #237 Gaithersburg, Md.—May 23, 2011— Today, at the American Society for Microbiology (ASM) Annual Meeting researchers at The University of Maryland
View HTML
Toggle Summary OpGen Announces Argus® Optical Mapping System Purchase by BGI
Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 Gaithersburg, Md.—February 8, 2011—OpGen, Inc., a genomics and DNA analysis company and exclusive provider of optical mapping technology, today announced that BGI, the largest genomics organization in the world, purchased an Argus
View HTML
Toggle Summary OpGen Announces Argus® Optical Mapping System Purchase by Wellcome Trust Sanger Institute - See more at: http://opgen.com/news/press-releases#sthash.IZ7mrxlV.dpuf
Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 Gaithersburg, Md.—January 6, 2011—OpGen, Inc. a commercial phase genomics and DNA analysis company, today announced that the Wellcome Trust Sanger Institute has purchased an Argus ™ Optical Mapping System in order to reduce the
View HTML
Toggle Summary OpGen, Inc., to Present at the Piper Jaffray 22nd Annual Health Care Conference
Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 OpGen, Inc., to Present at the Piper Jaffray 22nd Annual Health Care Conference Gaithersburg, Md. – November 30, 2010 – OpGen, Inc. a commercial phase genomics company, today announced that Douglas White, chief executive officer,
View HTML
Toggle Summary BGI and OpGen Collaborate on Use of Optical Mapping for Whole Genome Assembly - See more at: http://opgen.com/news/press-releases#sthash.IZ7mrxlV.dpuf
Media Contact: Dan Budwick Pure Communications, Inc. (973) 271-6085 Gaithersburg, Md. – November 4, 2010 – BGI, the largest genomics organization in the world, and OpGen, Inc., a commercial phase genomics company and exclusive provider of Optical Mapping Technology, announced their joint effort to
View HTML
Toggle Summary OpGen Completes $17 Million Series B Financing
Names Evan Jones as Executive Chairman of the Board Media Contac t: Dan Budwick Pure Communications, Inc. (973) 271-6085 Gaithersburg, Md. – September 27, 2010 – OpGen, Inc., a commercial phase genomics company, today announced the successful completion of a $17 million Series B equity financing.
View HTML